Stay updated on Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial page.

Latest updates to the Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedFooter updates add Revision: v3.3.3 and remove the HHS Vulnerability Disclosure link along with Revision: v3.3.2.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision from v3.2.0 to v3.3.2 appears on the page, a minor update that does not affect study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check59 days agoChange DetectedA government funding/status notice was removed from the page. No other content changes are visible.SummaryDifference0.4%

- Check74 days agoChange DetectedThe study details appear unchanged between the two screenshots; there are no updates to enrollment, outcomes, or contact information.SummaryDifference0.5%

- Check102 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference3%

Stay in the know with updates to Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of SCM-AGH in Atopic Dermatitis Clinical Trial page.